Us Physicalrapy Stock Performance
| USPH Stock | USD 76.04 0.13 0.17% |
The entity owns a Beta (Systematic Risk) of -0.0445, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning US Physicalrapy are expected to decrease at a much lower rate. During the bear market, US Physicalrapy is likely to outperform the market. At this point, US Physicalrapy has a negative expected return of -0.29%. Please make sure to validate US Physicalrapy's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if US Physicalrapy performance from the past will be repeated at some future date.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days US Physicalrapy has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
| Begin Period Cash Flow | 152.8 M |
USPH |
US Physicalrapy Relative Risk vs. Return Landscape
If you would invest 8,931 in US Physicalrapy on December 21, 2024 and sell it today you would lose (1,462) from holding US Physicalrapy or give up 16.37% of portfolio value over 90 days. US Physicalrapy is currently does not generate positive expected returns and assumes 1.5193% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of stocks are less volatile than USPH, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
US Physicalrapy Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for US Physicalrapy's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as US Physicalrapy, and traders can use it to determine the average amount a US Physicalrapy's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1883
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | USPH |
Estimated Market Risk
| 1.52 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average US Physicalrapy is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of US Physicalrapy by adding US Physicalrapy to a well-diversified portfolio.
US Physicalrapy Fundamentals Growth
USPH Stock prices reflect investors' perceptions of the future prospects and financial health of US Physicalrapy, and US Physicalrapy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USPH Stock performance.
| Return On Equity | 0.0646 | ||||
| Return On Asset | 0.0404 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 1.41 B | ||||
| Shares Outstanding | 15.19 M | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 2.37 X | ||||
| Price To Sales | 1.74 X | ||||
| Revenue | 560.55 M | ||||
| EBITDA | 86.91 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 153.6 M | ||||
| Debt To Equity | 0.57 % | ||||
| Book Value Per Share | 32.39 X | ||||
| Cash Flow From Operations | 74.94 M | ||||
| Earnings Per Share | 1.84 X | ||||
| Total Asset | 1.17 B | ||||
| Retained Earnings | 227.26 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
About US Physicalrapy Performance
By evaluating US Physicalrapy's fundamental ratios, stakeholders can gain valuable insights into US Physicalrapy's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if US Physicalrapy has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if US Physicalrapy has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company was founded in 1990 and is based in Houston, Texas. US Physical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 3158 people.Things to note about US Physicalrapy performance evaluation
Checking the ongoing alerts about US Physicalrapy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for US Physicalrapy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| US Physicalrapy generated a negative expected return over the last 90 days | |
| Over 98.0% of the company outstanding shares are owned by institutional investors |
- Analyzing US Physicalrapy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US Physicalrapy's stock is overvalued or undervalued compared to its peers.
- Examining US Physicalrapy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating US Physicalrapy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US Physicalrapy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of US Physicalrapy's stock. These opinions can provide insight into US Physicalrapy's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |